Market Overview

Research and Markets: Rhinovirus Infection - Pipeline Review, H2 2012


Research and Markets ( has announced the addition of Global Markets Direct's new report "Rhinovirus Infection - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Rhinovirus Infection - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rhinovirus Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rhinovirus Infection. Rhinovirus Infection - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


- A snapshot of the global therapeutic scenario for Rhinovirus Infection.

- A review of the Rhinovirus Infection products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Rhinovirus Infection pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

  • List of Tables
  • List of Figures
  • Introduction
  • Report Coverage
  • Rhinovirus Infection Overview
  • Therapeutics Development
  • An Overview of Pipeline Products for Rhinovirus Infection
  • Rhinovirus Infection Therapeutics under Development by Companies
  • Rhinovirus Infection Therapeutics under Investigation by Universities/Institutes
  • Late Stage Products
  • Comparative Analysis
  • Mid Clinical Stage Products
  • Comparative Analysis
  • Early Clinical Stage Products
  • Comparative Analysis
  • Rhinovirus Infection Therapeutics - Products under Development by Companies
  • Rhinovirus Infection Therapeutics - Products under Investigation by Universities/Institutes
  • Companies Involved in Rhinovirus Infection Therapeutics Development
  • Rhinovirus Infection - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Drug Profiles
  • Rhinovirus Infection Therapeutics - Drug Profile Updates
  • Rhinovirus Infection Therapeutics - Dormant Products
  • Rhinovirus Infection - Product Development Milestones
  • Featured News & Press Releases
  • Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation

For more information visit

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Respiratory

View Comments and Join the Discussion!

Partner Center